GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 23401 - 23450 of 40384 in total
PDB ID UniProt ID Title ▲ Descriptor
5KUY 5KUY Influenza hemagglutinin H3 A/Hong Kong/1/1968 in complex with designed inhibitor protein HSB.2A
3UBQ C3W5S1 Influenza hemagglutinin from the 2009 pandemic in complex with ligand 3SLN
3UBN C3W5S1 Influenza hemagglutinin from the 2009 pandemic in complex with ligand 6SLN
3UBJ C3W5S1 Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa
3UBE C3W5S1 Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTc
4HKX 4HKX Influenza hemagglutinin in complex with CH67 Fab
4HKX A7UPX0 Influenza hemagglutinin in complex with CH67 Fab
5UGY A7UPX0 Influenza hemagglutinin in complex with a neutralizing antibody
5UGY S6C4S0 Influenza hemagglutinin in complex with a neutralizing antibody
5UGY 5UGY Influenza hemagglutinin in complex with a neutralizing antibody
5UGY S6C4S0 Influenza hemagglutinin in complex with a neutralizing antibody
5UGY 5UGY Influenza hemagglutinin in complex with a neutralizing antibody
5UGY Q8N355 Influenza hemagglutinin in complex with a neutralizing antibody
5UGY Q8N355 Influenza hemagglutinin in complex with a neutralizing antibody
4KS1 Q0A480 Influenza neuraminidase in complex with antiviral compound (3S,4R,5R)-4-(acetylamino)-3-amino-5-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid
2IBX Q6DQ34 Influenza virus (VN1194) H5 HA
3W09 P03472 Influenza virus neuraminidase subtype N9 (TERN) complexed with 2,3-dif guanidino-neu5ac2en inhibitor
2YL8 P49610 Inhibition of the pneumococcal virulence factor StrH and molecular insights into N-glycan recognition and hydrolysis
1R4L Q9BYF1 Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2)
1R4L 1R4L Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2)
7NEU Q96IY4 Inhibitor Complex with Thrombin Activatable Fibrinolysis Inhibitor (TAFIa)
2PGB P00734 Inhibitor-free human thrombin mutant C191A-C220A
7AUW Q16820 Inhibitory complex of human meprin beta with mouse fetuin-B.
7AUW Q9QXC1 Inhibitory complex of human meprin beta with mouse fetuin-B.
8GYO Q96RD7 Inner channel lipids regulated gating mechanism of human pannexins.
5ZNS H9J9M0 Insect chitin deacetylase
5ZNT H9J9M0 Insect chitin deacetylase
1S78 P04626 Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
1S78 1S78 Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex
4DCH P35557 Insights into Glucokinase Activation Mechanism: Observation of Multiple Distinct Protein Conformations
5FQL P22304 Insights into Hunter syndrome from the structure of iduronate-2- sulfatase IDURONATE-2-SULFATASE (E.C.3.1.6.13)
7KD6 7KD6 Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b
7KD6 P06213 Insulin Receptor L1-CR plus alphaCT fragment in co-complex with Fv 83-7 and single-chain insulin SCI-b
6CE9 P06213 Insulin Receptor ectodomain in complex with two insulin molecules
6CE9 P01308 Insulin Receptor ectodomain in complex with two insulin molecules
6CE9 P01318 Insulin Receptor ectodomain in complex with two insulin molecules
6CEB P06213 Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry
6CEB P01308 Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry
6CEB P01318 Insulin Receptor ectodomain in complex with two insulin molecules - C1 symmetry
4OGA P01308 Insulin in complex with Site 1 of the human insulin receptor
4OGA 4OGA Insulin in complex with Site 1 of the human insulin receptor
4OGA P06213 Insulin in complex with Site 1 of the human insulin receptor
2HR7 P06213 Insulin receptor (domains 1-3)
5KQV P01317 Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE)
5KQV 5KQV Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE)
5KQV P06213 Insulin receptor ectodomain construct comprising domains L1,CR,L2, FnIII-1 and alphaCT peptide in complex with bovine insulin and FAB 83-14 (REVISED STRUCTURE)
3W12 P01308 Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7
3W12 3W12 Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7
3W12 P06213 Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alpha-CT peptide(704-719) and FAB 83-7
3W13 P01308 Insulin receptor ectodomain construct comprising domains L1-CR in complex with high-affinity insulin analogue [D-PRO-B26]-DTI-NH2, alphact peptide(693-719) and FAB 83-7

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024